Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex by Gabrielli, Brian G. et al.
THE  JOURNAL 
0 1992 by The American Society for Biochemistry and Molecular Biology, Inc. 
OF BIOLOGICAL CHEMISTRY Vol. 267, No. 25, Issue of September 5, pp. 18040-18046,1992 
Printed in U.S.A. 
Cdc25 Regulates  the  Phosphorylation  and  Activity of the Xenopus 
cdk2 Protein  Kinase  Complex* 
(Received for publication, April 10, 1992) 
Brian G. GabrielliS, Margaret S. Leegll, Duncan H. Walker$, Helen Piwnica-WormsllI,  and 
James L.  MallerS** 
From the $Howard Hughes Medical Institute and Department of Pharmacology, University of Colorado School of Medicine, 
Denver, Colorado 80262 and the  §Department of Physiology, Tufts  University,  Boston,  Massachusetts 021 11 
The Xenopus cdk2 gene  encodes a 32-kDa  protein 
kinase  with sequence similarity  to  the  34-kDa  product 
of the cdc2 gene. Previous  studies  have shown that  the 
kinase  activity of the  protein  product of the  cdk2 gene 
oscillates  in the Xenopus embryonic  cell  cycle  with a 
high  in "phase and a low in  interphase.  In  the  present 
study  cdk2  was found  not to be  associated with  any 
newly  synthesized proteins  during  the cell cycle, but 
the enzyme did undergo periodic changes in phos- 
phorylation. Upon exit  from  metaphase, cdk2 became 
increasingly  phosphorylated  on  both tyrosine  and 
serine residues, and labeling on these residues in- 
creased progressively until  entry  into mitosis, when 
tyrosine residues were markedly dephosphorylated. 
Phosphopeptide mapping of cdk2 demonstrated the 
major  sites of phosphorylation were  in a phosphopep- 
tide  with a PI of 3.7 that  contained both  phosphoserine 
and phosphotyrosine. This phosphopeptide accumu- 
lated  in egg extracts blocked in  S-phase  with  aphidi- 
colin and  was not evident  in cdc2  immunoprecipitated 
under  the same conditions. Under  the  same conditions 
cdc2  was  phosphorylated primarily on  a phosphopep- 
tide  containing both  phosphothreonine and phospho- 
tyrosine residues, most likely  threonine 14  and  tyro- 
sine 15. Affinity-purified  human  GST-cdc25  was  able 
to dephosphorylate and activate cdk2 isolated from 
interphase cells. Phosphopeptide  mapping demon- 
strated  that  the phosphate was specifically removed 
from  the same  phosphopeptide  identified as the major 
in vivo  site of phosphorylation.  These results demon- 
strate  that  cdk2 is regulated  in  the cell cycle by phos- 
phorylation  and dephosphorylation  on  both serine  and 
tyrosine residues.  Moreover, the  increased phosphoryl- 
ation of cdk2  in aphidicolin-blocked extracts  and  the 
ability of cdc25  to  mediate  cdk2  dephosphorylation i  
vitro suggest the possibility that  cdk2 is part of the 
mechanism ensuring mitosis is not initiated  until com- 
pletion of  DNA replication. It also  implies  cdc25 may 
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have  other  functions  in  addition  to  the  regulation of 
dc2 kinase  activity. 
A major advance in cell  cycle research in the  past several 
years  has come from the elucidation of the function of the 
cdc2/CDC28 gene product. This advance stemmed from the 
discovery that cdc2 is the catalytic subunit of an enzyme 
known as maturation-promoting factor (Lohka et al., 1988; 
Gautier et al., 1988; Dunphy et al., 1988). This enzyme had 
been identified in meiosis and mitosis from a wide range of 
cell types as sufficient to catalyze the  entry of Gz-arrested 
frog oocytes into meiosis in the absence of  new protein  syn- 
thesis  (Kishimoto et al., 1982). A kinase related to  the cdc2 
gene product was also subsequently identified as a component 
of the mammalian growth-associated histone H1 kinase, 
whose activity correlates with chromosome condensation and 
the proliferative state of cells (Langan et al., 1989). Since the 
cdc2 gene controls entry  into mitosis in cells from yeast to 
humans, its regulation is clearly highly conserved and of 
fundamental  importance in biology. 
Active  cdc2 kinase is a complex of the cdc2  gene product 
with a cyclin (Lohka et al., 1988; Draetta et al., 1989;  Labb6 
et al., 1989; Gautier et al., 1990). The cyclins are characterized 
by their periodic accumulation and destruction  (Minshull et 
al., 1989), and  their association with ~ 3 4 ' ~ " '  is necessary for 
the activation of cdc2 kinase and for entry of cells into mitosis 
(Murray and Kirschner, 1989). Cyclins fall into two general 
classes, G,/M cyclins (A and B) and G1 cyclins (C, D, and E) 
(Hunter  and Pines, 1991; Pines and Hunter, 1991a, for re- 
view). Purified  maturation-promoting factor is a complex of 
~ 3 4 " ~ ~ '  and cyclin B (Gautier et al., 1990; Hunter  and Pines, 
1991; Labbir et al., 1989; Meijer et al., 1989). Cyclin A also 
forms active kinase complexes with ~34"~" ' ,  although the 
kinetics of cyclin A/cdc2 kinase activation and inactivation 
differ from the cyclin B complexes (Minshull et al., 1990; 
Walker and Maller, 1991). In addition to a requirement for 
cyclin association, activation of cdc2 kinase involves a com- 
plex series of phosphorylation and dephosphorylation events 
on the cdc2 subunit. In  the case of cyclin B, newly synthesized 
protein associates with ~ 3 4 ~ ~ "  and induces its phosphorylation 
on Thr14 and Tyr15 in the ATP-binding site  to form a  catalyt- 
ically inactive complex (Solomon et al., 1990; Parker et al., 
1991). This complex is then abruptly  activated at  the  G2/M 
boundary by an obligatory dephosphorylation of ThrI4  and 
Tyr15. In Schizosaccharomyces pombe only Tyr15 is phos- 
phorylated, and substitution of this residue with phenylala- 
nine results in premature entry into mitosis (Gould and 
Nurse, 1989), indicating this dephosphorylation event is a key 
step in entry  into mitosis. The timing of TyrI5 dephosphoryl- 
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ation  and cdc2 kinase activation is dependent upon the com- 
pletion of DNA replication, as  the presence of unreplicated 
DNA blocks tyrosine dephosphorylation and leads to accu- 
mulation of the inactive tyrosine-phosphorylated complex 
(Dasso and Newport, 1990; Kumagai and Dunphy, 1991). 
From genetic studies, the weel+ gene is known to encode a 
dose-dependent  inhibitor, and  the cdc25' gene a  dose-depend- 
ent activator, of the cdc2 kinase (Russell and Nurse, 1986, 
1987).  Recent  studies show that direct  phosphorylation/de- 
phosphorylation of TyrI5  in ~34'~' '  underlies these dose-de- 
pendent effects. The cyclin/cdc2 complex is a substrate for 
the dual specificity kinase  weel, which phosphorylates Tyr" 
in cdc2 (Parker et al., 1991, 1992), and  the inactive complex 
can be activated in  vivo and in  vitro by the action of the cdc25 
gene product, which has been shown to possess intrinsic 
tyrosine phosphatase activity (Dunphy and Kumagai, 1991; 
Gautier et al., 1991; Lee et al., 1992; Strausfeld et al., 1991). 
A protein with a high degree of sequence identity to  p3PdC2, 
originally known as Egl but now termed cyclin-dependent 
kinase 2 or cdk2 (Paris et al., 1991), has been studied recently 
in Xenopus eggs, where it is present both  as a high molecular 
weight complex with histone H1 kinase activity and as a 
catalytically inactive monomer (Gabrielli et al., 1992). In yeast 
it is well established that cdc2' regulates the cell cycle at both 
the G1/S and  the G2/M  restriction  points. Xenopus cdk2 will 
not complement mutations in cdc2' in S. pombe or CDC28 in 
S. cerevisiae that involve G2/M regulation (Paris et al., 1991). 
However, when co-expressed with a human G1 cyclin E, 
Xenopus cdk2 will substitute for CDC28 in S. cerevisiae at 
the  GI/S restriction  point (Koff et al., 1991), suggesting that 
in higher eukaryotes at  least some aspects of  G1/S regulation 
involve cdk2 rather  than cdc2. 
In embryonic cell  cycles, the activity of cdk2 oscillates with 
a periodicity similar to  that of cdc2, but with a more modest 
change in activity (only 2-%fold elevation in "phase com- 
pared with >10-fold for cdc2) (Gabrielli et al., 1992). In 
mammalian cells some fraction of cyclin A has been reported 
to be associated with cdk2 (Tsai et al., 1991, Elledge et al., 
1992; Rosenblatt et al., 1992). However, in Xenopus eggs cdk2 
is apparently  not associated with either of the mitotic cyclins, 
and  the kinetics of its activation and inactivation are  not  as 
abrupt  as observed for cyclin B/cdc2 complexes (Gabrielli et 
al., 1992; Solomon et  al., 1990; Minshull et al., 1990). 
In  this paper, we have investigated the mode of regulation 
of the Xenopus cdk2 H1 kinase. Our results  indicate that  the 
protein kinase activity of cdk2 is regulated by phosphorylation 
of the kinase subunit itself. A single major phosphopeptide 
from cdk2 labeled in  egg extracts  has been identified, and we 
demonstrate that in vitro the cdc25 phosphatase catalyzes 
dephosphorylation of this phosphopeptide coincident with 
activation of the kinase to levels similar to those seen in  vivo 
a t  mitosis. 
MATERIALS AND  METHODS 
Preparation of Eggs and Extracts-Cytostatic factor/metaphase- 
arrested  extracts were prepared by a modification of the method of 
Lohka  and Maller (1985) as described in Murray et al. (1989) except 
that leupeptin was omitted from all buffers. Aliquots were taken  at 
the indicated  times, and sequential cdk2 and  pl3-Sepharose precipi- 
tations for H1 kinase  assays were performed as described previously 
(Gabrielli et al., 1992), using a buffer containing 10 mM @-glycero- 
phosphate, 5 mM NaF, 0.2% Triton X-100 and 0.1 M NaC1. In  the 
case of "P-labeled extracts, the concentrations of added phospho- 
creatine  and ATP were decreased to 0.38 mM and 50 p~ respectively. 
:"PI (2 mCi/lOO-pl extract) was added at time zero, and in some 
experiments,  a further 1 mCi of [Y-~'P]ATP was added 20 min prior 
to the termination of the reaction. Thin-layer chromatography of 
extracts demonstrated the added radioactivity equilibrated rapidly 
with ATP pools, and  the specific activity  remained constant for the 
duration of the labeling experiments. The samples were stored at 
-80 'C until analyzed. 
Sperm pronuclei were prepared as described in Lohka and Maller 
(1985) and added to the extract to a final concentration of 2000 
pronuclei/pl. Baculovirus-expressed GST-cdc25 was produced as fol- 
lows: pML25  (Lee et al., 1992) was partially digested with EcoNI and 
ligated to two partially overlapping oligonucleotides 5"TCTA- 
GATGCCTAT-3' and 5-TATAGGCATCTAGA-3' to generate 
pML25X. This  step  inserts a unique XbaI site  and a new in-frame 
initiation  site at  the extreme  N terminus of the  GST gene. pML25- 
X was completely digested with  XbaI and SrnaI, and  the 2.5-kb' insert 
containing the full length cdc25 gene fused to the GST gene was 
ligated into  XbalSrnaI linear pVL1392 (Piwnica-Worms, 1990). The 
resulting plasmid pVLGST-25 was used to generate recombinant 
virus. Sf9 cells (3 X lo6) were infected at   an multiplicity of infection 
of approximately 10. At  40 h after infection, cells were harvested and 
frozen at  -80. Cells were lysed by sonication in NETN buffer (20 
mM Tris,  pH 8.0, 2 mM EDTA, 100 mM NaCI, 0.5% Nonidet  P-40, 
0.5 mM phenylmethylsulfonyl fluoride, 10 pg/pl of each of leupeptin, 
pepstatin, chymostatin, and  aprotinin).  The lysates were rotated at  
4 "C for 10 min, then centrifuged 10' in a microcentrifuge and  the 
supernatant (normally 500 pl) was added to 60 pl of glutathione- 
agarose beads. The  supernatant  and beads were mixed by rotation 
for 40' min at  4  "C, then  the beads were pelleted and washed with 
NETN buffer. The  protein was used either bound to  the glutathione- 
agarose beads or after elution  with  10 mM glutathione. 
Phosphoamino Acid Analysis and Tryptic Peptide Mapping of cdc2 
and cdk2-After thawing, 100-pl samples of 32P-labeled egg extract 
were diluted with 100 p1 of extraction buffer (EB, Gabrielli et al., 
1992) containing  2 mM sodium vanadate  and 50 mM p-nitrophenyl 
phosphate. The 200-ul samples were precleared by incubation with 
50 pl of 50% protein A-Sepharose  suspension at 4 "C for 30 min with 
gentle rotation, followed by centrifugation for 5 min at  15,000 X g in 
a microcentrifuge. The  supernatant was incubated  overnight with 15 
pg of affinity-purified cdk2 antibody  (Gabrielli et al., 1992), precipi- 
tated with 40 pl of 50% protein A-Sepharose  suspension for 1 h  with 
gentle rotation,  and collected by centrifugation in a microcentrifuge. 
The  supernatant was then incubated  with  sheep  anti-Xenopus cyclin 
B2 IgG fraction (20 pg; Izumi and Maller, 1991) for 4 h at 4 "C, 
followed by precipitation  with 40 pl of a 50% suspension of protein 
G-Sepharose for 1 h at  4 "C. The immunoprecipitates were washed 
with RIPA buffer supplemented with 2 mM sodium vanadate, 0.2 mM 
ammonium molybdate, 80 mM @-glycerophosphate,  10 mM NaF, and 
20 mM p-nitrophenyl  phosphate as described in Gautier et al. (1989). 
The washed immunoprecipitates were electrophoresed  on 12.5% SDS- 
polyacrylamide gels (Laemmli, 1970) and electrotransferred to either 
polyvinylidene difluoride or nitrocellulose membranes for phosphoa- 
mino acid analysis or  tryptic phosphopeptide  mapping, respectively. 
Transfer  to polyvinylidene difluoride membranes was performed on 
an LKB semi-dry apparatus using 10 mM CAPS, pH 11, in 10% 
methanol as  the  transfer buffer (Matsudaira, 1987). The bands cor- 
responding to labeled cdk2 and cdc2 were cut  out,  and two-dimen- 
sional phosphoamino acid analysis was performed as described by 
Kamps  and Sefton (1989). Transfer  to nitrocellulose was performed 
using a wet transfer  apparatus (Hoeffer) in 192 mM glycine, 10 mM 
Tris, 0.01% SDS, and 20% methanol,  overnight at  35 V with cooling. 
Quantitative  transfer was obtained using these  conditions. The 32P- 
labeled bands were excised and blocked with 1% gelatin for 2 h at  
37 "C. The nitrocellulose pieces were then washed with 50 mM am- 
monium bicarbonate, 5%  CH&N  and digested overnight with 50 pg/ 
ml L-1-tosylamido-2-phenylethyl chloromethyl  ketone-treated tryp- 
sin in the  same buffer a t  37 "C. The membrane pieces were washed 
again with the same buffer, and the washes were pooled, dried, 
redissolved in 0.1 M acetic acid and dried again. The samples were 
dissolved in 20 @I of 0.1 M acetic acid and spotted onto small  filter 
paper discs. The  tryptic phosphopeptides were analyzed by isoelectric 
focussing in a Bio-Rad flat-bed apparatus using ultrathin-layer (0.2 
mm) polyacrylamide gels containing a  mixture of 1 part  pH 3-10 and 
4 parts  pH 3-5 ampholines (Serva) with 5% (v:v) phosphoric acid as 
the anodic buffer and 1 M NaOH  as  the cathodic buffer. The sample 
discs were placed a third of the gel length from the cathode. The 
focussing was performed at  1500 V and 15 mA for 50 min, after which 
the gels were air-dried and autoradiographed. Resolved phosphopep- 
tides were eluted from excised gel pieces overnight in 50 mM ammo- 
' The abbreviations used are: kb,  kilobase(s); SDS, sodium dodecyl 
sulfate; CAPS, 3-(cycloheylamino)propanesulfonic acid. 
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nium bicarbonate containing 5% CH3CN, dried, hydrolyzed, and 
analyzed for phosphoamino acid content by two-dimensional thin- 
layer  electrophoresis as described above. Thin-layer chromatography 
of bands eluted from isoelectric focussing gels was performed by 
spotting samples onto cellulose  sheets (Kodak), and the chromato- 
gram  developed in n-butanol,  pyridine,  acetic  acid,  water  (63.3:1:4). 
In  Vitro cdc25 Assays-Either unlabeled or "P-labeled  cdk2  im- 
munoprecipitates from  DNA- and aphidicolin-blocked interphase 
extracts (Walker and Maller, 1991) were used as substrates for 
dephosphorylation by recombinant  GST-cdc25 that had been  purified 
by affinity chromatography  on  glutathione-agarose.  Immunoprecipi- 
tates were  incubated with the indicated amount of affinity-purified 
GST-cdc25 in 25 mM imidazole, pH 7.2, 1 mM EDTA, 0.1% 2- 
mercaptoethanol, 0.1 mg/ml bovine serum albumin for 40 min at 
25 "C. The H1 kinase activity of the unlabeled samples was assayed 
after washing the precipitates, and the sites in radiolabeled cdk2 
dephosphorylated by  cdc25  were determined by tryptic phosphopep- 
tide mapping and autoradiography as described above. 
RESULTS 
It  has been  previously shown  that  cdk2 H 1  kinase  activity 
oscillates during the embryonic cell cycle (GabrieUi et al., 
1992). In  this respect, it  is  reminiscent of cdc2 kinase,  the 
activity of which has been shown  to  be regulated in  part by 
the  accumulation  and  destruction of its  associated cyclin  B 
subunit  (Murray  and  Kirschner, 1989). Whereas  cyclins A, 
B1, and  B2 were easily detectable  in cdc2 immunoprecipitates 
from ["S]methionine-labeled egg extracts,  no labeled proteins 
were specifically precipitated by cdk2 antibodies even with 
exposures 40 times longer than necessary to  detect  the cdc2- 
associated cyclins (Fig. 1). This is consistent with earlier 
results  that  demonstrated  the  activation f cdk2 H 1  kinase a t  
mitosis was not affected  by inhibiting  protein  synthesis  (Ga- 
" 
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FIG. 1. Immunoprecipitation of cdk2 and cdc2. Cdk2 and 
cdc2  immunoprecipitates were prepared  from  [%]methionine-labeled 
egg extracts (0.5 mCi/ml) containing 2000  sperm pronucleilpl80 min 
after release from metaphase arrest by  calcium addition.  Immunopre- 
cipitation was in RIPA  buffer containing 0.4 M NaCl to extract all 
chromatin-bound complexes. The cdc2 antibody was raised against a 
synthetic peptide corresponding to the last 15 residues at the C, 
terminus of Xenopus cdc2, and cdk2  antibody  was  raised against a 
peptide corresponding to the last 15 residues at its C terminus. 
Neither  antibody  cross-reacted with the other kinase.  Each  antibody 
was used at a dilution sufficient to completely immunodeplete its 
respective target protein  from the extract. The -80-kDa  band in the 
cdk2  immunoprecipitate  is  probably  nonspecific, as a band of similar 
molecular  mass and  intensity was also apparent in the cdc2  immu- 
noprecipitate. Labeled bands were detected by fluorography for 2 
weeks, and the faint 32-kDa band is cdk2.  Blocking was performed 
by incubating the IgG with 2 pg of immunogen peptide per pg of 
antibody  prior to immunoprecipitation. Arrows denote the position 
of cyclins A, B1, and B2 on the left,  and molecular  mass markers in 
kDa are on the right. 
brielli et al., 1992). We  have  also  shown  that active  cdk2 exists 
as a high  molecular  weight complex. Gel filtration  analysis of 
high  speed supernatants  from unfertilized eggs or ionophore- 
activated eggs a t  either  interphase  or  the  first  mitotic  meta- 
phase showed significant  amounts of cdk2 in  an M ,  200,000 
complex a t  all times (Gabrielli et al., 1992 and data not 
shown).  These  results  indicate  that unlike cdc2, the  activation 
and inactivation of cdk2 in the embryonic cell cycle are 
apparently not due to the synthesis and destruction of a 
cyclin-like subunit. 
The Phosphorylation State of cdk2 Changes during  the Cell 
Cycle-Given the  precedent of direct regulation of cdc2 by 
phosphorylation,  an obvious question concerned whether cdk2 
was also regulated  via  phosphorylation. Extracts  from  unfer- 
tilized eggs that progressed through  the cell cycle following 
addition of Ca2+ were incubated with  2 mCi of  32P, and cdk2 
was immunoprecipitated a t  various times (Fig. 2). It was 
routinely possible to  obtain 500 cpm in  cdk2/100 pl of extract 
by this method. Phosphoproteins of 95, 60, and a doublet of 
32-33 kDa were specifically precipitated by the  cdk2  antibody 
(Fig. 2c). The 32-33-kDa doublet could also be detected by 
PSTAIR immunoblotting of similar unlabeled cdk2 immu- 
noprecipitates. The 95- and  60-kDa  bands were precipitated 
by the  cdk2  antibody even in  samples from maturing oocytes 
where  cdk2  was ablated by specific antisense oligodeoxynu- 
cleotide treatment (data not shown), suggesting that these 
two proteins were precipitated  through  direct  interaction with 
the  antibody  and  not  indirectly  through association  with cdk2. 
The cyclin B2 antibody  precipitated two major  phosphopro- 
teins,  the 45-kDa cyclin B2 and  the 34-kDa cdc2 (Izumi and 
Maller, 1991). 
The  phosphoamino acid content of cdk2 changed during 
the embryonic cell cycle (Fig. 2b). Phosphoserine was  found 
throughout  the cycle, but  its relative intensity increased pro- 
gressively after  exit from metaphase (30 and 60 min, Fig. 2b). 
Phosphotyrosine was also observed in cdk2. This  appeared in 
the  earliest  time  point  taken  after  exit  from  metaphase (30 
min), paralleling the decrease in cdk2 activity. It was not 
detectable in first mitotic metaphase (150 min) when cdk2 
activity  had  returned  to maximal. Low levels of phosphothre- 
onine were also observed and  appeared  to  parallel  the incor- 
poration of phosphotyrosine. Thus,  there  are several phos- 
phorylation  sites,  and  it  is likely that a number of different 
protein  kinases  and  phosphatases may act  on cdk2. 
Tryptic Phosphpeptide  Mapping of cdk2"The  almost com- 
plete sequence identity of potential  tryptic  fragments of cdk2 
and cdc2 that would contain known cdc2 phosphorylation 
sites, including ThrI4, TyrI5, ThrIfi1, and Ser'l7' (Gould and 
Nurse, 1989; Krek  and Nigg, 1991a), facilitated  the analysis 
of phosphorylation  sites in  cdk2  by comparative  tryptic phos- 
phopeptide mapping. Both "'P-labeled cdk2 and :j2P-labeled 
cyclin B2-associated cdc2 were isolated from  metaphase-ar- 
rested extracts induced to cycle by calcium addition, using 
sequential immunoprecipitation with the appropriate anti- 
bodies. The cdk2 and cdc2 bands were excised from the gel, 
digested with  trypsin,  and analyzed by isoelectric focussing in 
ultrathin-layer polyacrylamide gels. 
The major tryptic  phosphopeptide derived from cdk2 a t  all 
stages of the cell cycle had a PI of  3.7 (Fig. 3a). This species 
was abundant  during  interphase (30 and 90 min)  and  then 
decreased with activation of cdk2 a t  metaphase (150 min). 
Densitometry of several experiments of this type revealed 
that  the labeling of this  band decreased 60-90% upon entry 
into mitosis. Phosphoamino acid analysis of this major cdk2 
phosphopeptide revealed the presence of equal amounts of 
phosphoserine and phosphotyrosine (Fig. 3c, panel 1). Ex- 
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FIG. 2. Changes in phosphoamino 
acid  content of cdk2  during  the cell 
cycle. The H1 kinase activity of cdc2 
and cdk2 was determined  after  Ca2+-in- 
duced release of metaphase  arrest  in  the 
extract as described under “Materials 
and Methods” ( a ) .  The phosphoamino 
acid  content  (b) of cdk2  immunoprecip- 
itated from the  extracts following release 
from  metaphase  arrest at  the  times  in- 
dicated was determined by two-dimen- 
sional  thin-layer  electrophoresis  and  au- 
toradiography  as described under “Ma- 
terials  and  Methods.” c, Cdk2 was 
immunoprecipitated 150 min after cal- 
cium  addition from  ‘”P-labeled extracts 
in the presence (block +) or  absence 
(block -) of the immunogen peptide  and 
analyzed by SDS-gel electrophoresis  and 
autoradiography. 
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FIG. 3. Phosphopeptide mapping of cdc2 and cdk2. a, isoelectric  focussing analysis of tryptic  phosphopeptides  generated from  cdk2 
and cyclin B2-associated cdc2 during  the  first  mitotic cycle. “‘P-Labeled samples were taken at   the indicated  times,  and cdk2 and cdc2 were 
isolated by immunoprecipitation  and digested with  trypsin  as described under  “Materials  and Methods.” As described in  the  text,  bands 
corresponding to cdc2-derived phosphopeptides  are  numbered  on  the  right  from 1-7 from  top  to  bottom,  and  the position of PI marker 
proteins  are indicated on  the left. The arrow indicates  the  position where samples were loaded on  the gel. The radioactive bands  evident a t  
this position are precipitated during loading of the  sample  and  are  not  seen  consistently  in  other  experiments (cf. Fig. 5c). b, thin-layer 
chromatography of the PI 3.7 cdk2- and cdc2-derived phosphopeptides (phosphopeptide 2 area). c, two-dimensional phosphoamino acid 
analysis of the major band of cdk2-derived phosphopeptide ( I )  and cdc2-derived band 1 (2). 
tended autoradiography of the  tryptic map revealed the pres- 
ence of a number of minor tryptic phosphopeptides (not 
shown). These may account for the low level of phosphothre- 
onine  and  the metaphase  phosphoserine content of cdk2. 
Isoelectric focussing of the cdc2-derived tryptic phospho- 
peptides showed a more complex pattern. One  phosphopeptide 
(PI 3.7 cdc2 band 2) appeared to co-migrate with the major 
cdk2-derived phosphopeptide (Fig. 3a) .  However, when the 
two peptides were eluted and  run  in a second dimension on 
thin-layer chromatography, they were easily resolved (Fig. 3b) 
suggesting the phosphopeptides were not identical. The cdc2- 
derived band 2 may represent the Tyr15-monophosphorylated 
tryptic fragment, based on its phosphoamino acid content  and 
its insensitivity to dephosphorylation by protein  phosphatase 
1 (data  not shown). 
It was possible to tentatively identify the major site of 
mitotic regulation on cdc2, Thr14/Tyr15, as being contained in 
peptide 1, which had  a PI of  2.4. Phosphoamino acid analysis 
of the phosphopeptide revealed only phosphothreonine and 
phosphotyrosine (Fig. 3c, panel Z), and it was detected in 
tryptic maps of cdc2 only during GP phase of the embryonic 
cell cycle (-90 min) just prior to  the mitotic activation of 
cdc2 kinase (data  not shown). Phosphopeptides in  bands 3 , 4 ,  
and 5 contained only phosphoserine, while some phosphoty- 
rosine was also detected in band 7 ,  and a low level of phos- 
phothreonine in addition to phosphoserine was detected in 
band 6 (see Fig. 5a).  The variability and more neutral PI of 
bands 6 and 7 suggest these may represent incomplete diges- 
tion products. 
Unreplicated DNA has been demonstrated to inhibit  the 
activation of cyclin Blcdc2, resulting  in the accumulation of 
tyrosine-phosphorylated cdc2 in the cyclin B complex (Dasso 
and Newport, 1990; Kumagai and Dunphy, 1991; Walker and 
Maller, 1991). This appears to be due to the inhibition of 
Tyr15 dephosphorylation, and probably also Thr14 dephospho- 
rylation by  cdc25. Consistent with this notion, addition to 50 
pg/ml of the DNA synthesis  inhibitor aphidicolin in extracts 
containing pronuclei completely blocked the normal activa- 
tion of cdc2 at  metaphase, and, importantly, also blocked the 
activation of cdk2 (Fig. 4). Tryptic phosphopeptide maps of 
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cdk2 from such DNA/aphidicolin-blocked samples  contained 
an  elevated level of the PI 3.7 phosphopeptide (Fig. 3a, 150*). 
This was further evidence that phosphorylation of this  tryptic 
fragment was  closely associated with decreased cdk2 kinase 
activity. Only the phosphopeptide designated band 1 accu- 
mulated in cdc2-derived maps from similar  samples (see Fig. 
5c), consistent with the reported  accumulation of phospho- 
tyrosine on cdc2 under similar conditions (Kumagai and 
Dunphy, 1991) and the notion that the ThrI4/Tyrl5 sites 
regulate the activation of cdc2 kinase at  mitosis. 
Regulation of cdk2 Phosphorylation and Activity by  cdc25- 
Given the evidence described above that cdk2 was negatively 
regulated by tyrosine phosphorylation, it was important  to 
evaluate  whether cdc25 could act on the cdk2 complex. The 
addition of affinity-purified GST-cdc25 to DNA/aphidicolin- 
blocked interphase egg extracts resulted  in the activation of 
cdc2 kinase as reported previously (Kumagai and Dunphy, 
1991), but cdk2 was also activated to metaphase levels (Fig. 
5a) .  There was no appreciable lag before activation of cdk2 
kinase after addition of the cdc25, suggesting that cdc25 may 
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FIG. 4. Inhibition of DNA synthesis blocks activation of 
both cdc2 and cdk2. The cdk2  and cdc2 H1 kinase  activities were 
assayed a t  various times  after calcium addition to metaphase-arrested 
extracts containing 2000 pronuclei/pl in the absence (circles) or 
presence  (squares) of 50 pg/ml  aphidicolin. 
act directly on cdk2 to dephosphorylate and activate the 
kinase. This direct mechanism was supported by the demon- 
stration that cdk2 immunoprecipitates from DNA/aphidi- 
Colin-blocked extracts were activated for H1 phosphorylation 
by incubation with GST-cdc25 to levels 50% above control 
levels (Fig. 5b). Similar  results were obtained with cyclin  B2- 
immunoprecipitated cdc2 kinase from cdk2-immunodepleted 
samples, although the degree of activation varied from 50 to 
200% depending on the experiment (Fig. 5b). The degree of 
activation of both cdk2 and cdc2 was less than  that observed 
when cdc25 was added to the interphase-blocked extracts. 
This may  be due  in part  to  the l sser amount of cdc25 protein 
used in the in vitro activation (0.15  pg compared to 1 pg added 
to  the  extract)  or  to physical constraints in the immunopre- 
cipitate. 
Incubation of 32P-labeled cdk2 and cyclin B2 immunopre- 
cipitates from DNA- and aphidicolin-blocked extracts with 
GST-cdc25 resulted  in the specific dephosphorylation of the 
cdk2 and cdc2 phosphoproteins (data not shown). Tryptic 
phosphopeptide mapping of the labeled cdk2 revealed the 
dephosphorylation of the PI 3.7 band,  without the appearance 
of a new more basic phosphopeptide, suggesting that cdc25 
dephosphorylated both serine and tyrosine in this peptide 
(Fig. 5c). The decrease in  the PI 3.7 band  after cdc25 treatment 
was quantified by densitometry  in four separate experiments 
to be between 50 and 70%. 
The putative  Thr’4/Tyr’5-containing  band 1 was the major 
site of cdc25 action  on cdc2. The two most basic bands, 6 and 
7, were also diminished, supporting the notion that they 
represent incomplete tryptic digestion products. Band 2 in 
cdc2 was also dephosphorylated. The  other major cdc2 phos- 
phopeptides were unaffected. The dephosphorylation of band 
1 went to near completion and no new, more basic band 
representing a monophosphorylated peptide was detected, 
indicating the likelihood that cdc25 dephosphorylated both 
threonine  and tyrosine residues in this peptide. The apparent 
ability of cdc25 to dephosphorylate all three types of phos- 
phorylated residues is not unexpected, since cdc25 appears to 
be distantly related to a newly discovered class of “dual 
specificity” serine/threonine and tyrosine  phosphatase (Gau- 
tier et al.. 1991 and references therein). 
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FIG. 5. cdc25 dephosphorylates and activates both cdk2 and cdc2. a, cdk2  and cdc2 H1  kinase  activities were assayed from either 
DNA/aphidicolin-blocked interphase  extracts (circles) or  similar  extracts  to which  purified GST-cdc25 (1 pg of protein;  squares) was added 
after 80 min. b, immunoprecipitates of either  cdk2 or cyclin  B2-associated cdc2 from DNA/aphidicolin-blocked extracts (samples taken a t  
120  min) were incubated with either buffer alone  or  GST-cdc25 (0.15 pg of protein),  then washed and assayed for H1 kinase  activity. The 
values  are  the  mean -C S.E. of five separate  experiments.  In  some  experiments  the  control  addition was  baculovirus-expressed GST  protein 
purified by glutathione-Sepharose, using the procedure described for GST-cdc25. c, similar DNA/aphidicolin-blocked samples from ”p- 
labeled extracts were immunoprecipitated as in b and incubated with either buffer or GST-cdc25 (1.2 pg) then analyzed by tryptic 
phosphopeptide mapping. 
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DISCUSSION 
Similarities and differences in  the regulation of cdk2 and 
cdc2 are evident from the  data in this paper. In  the Xenopus 
embryonic egg cell cycle, the synthesis and destruction of 
cyclin B has been shown to be a major controlling  factor in 
the regulation of mitotic cdc2 kinase activity (Murray and 
Kirschner, 1989; Murray et al., 1989), although the presence 
of unreplicated DNA will activate an otherwise dormant 
checkpoint (Dasso and Newport, 1990; Walker and Maller, 
1991). Unlike cdc2 however, cdk2 in Xenopus eggs appears  to 
form a stable complex with unidentified proteins,* and  the 
activity of the complex is  regulated by phosphorylation of the 
cdk2  protein and  not by association  with newly synthesized 
proteins (Fig. 1). This agrees with earlier results  that dem- 
onstrated cdk2 activation was independent of protein  synthe- 
sis (Gabrielli et al., 1992). The failure to detect cdk2/cyclin A 
complexes in the Xenopus embryonic  system  is apparently a t  
odds with recent  results from a  number of groups that have 
demonstrated  that cdk2 is  associated  with cyclin A  in  somatic 
cell systems (Tsai et al., 1991; Elledge et aL, 1992; Rosenblatt 
e t  al., 1992). In  fact, we have detected  only cdc2 associated 
with cyclin A in Xenopus eggs. However, large differences in 
the association of cyclin A with cdc2 and cdk2 have been 
reported between adherent  and suspension-grown HeLa cells 
and in  various other cell types (Elledge et al., 1992), suggesting 
that  the relative  proportion of cyclin A complexed with cdc2 
and cdk2 varies  with  different cell types and with  different 
growth conditions. 
Our data indicate that  the regulation of cdk2 kinase  in the 
Xenopus embryonic cell cycle is  due  primarily to  the specific 
phosphorylation and dephosphorylation of the cdk2 protein 
subunit.  The major cdk2-derived tryptic phosphopeptide  is  a 
phosphoserine- and phosphotyrosine-containing species and 
was not evident in  the cdc2-derived phosphopeptides.  While 
we have only tentatively identified the cdc2-derived Thr14/ 
Tyr"-containing phosphopeptide, it is clearly evident that 
this same  site, which is conserved in the cdk2 sequence, is not 
the major site of cdk2 kinase  regulation.  Identification of the 
major cdk2 regulatory site will require more complete  mapping 
and sequence analysis. We have also demonstrated  that cdc25 
acts directly on  the unique  phosphoserine- and phosphotyro- 
sine-containing phosphopeptide to activate the cdk2 H1 ki- 
nase. The phosphorylation and subsequent  dephosphorylation 
of this phosphopeptide  most closely correlated  with the inac- 
tivation  and reactivation of the cdk2 complex during the cell 
cycle. These data together strongly suggest that the sites 
contained in this phosphopeptide are of major importance  for 
cdk2 regulation. 
Our experiments support  the idea that  the dephosphoryla- 
tion of Thr14/Tyr15 in cdc2 by cdc25 is a major regulatory 
mechanism for activation of the Xenopus enzyme. These  data 
are in  agreement  with those of others who have shown that 
dephosphorylation of this  site is temporally  related to  acti- 
vation of the cyclin B-cdc2 complex at  the G2/M  boundary of 
the cell cycle (Gould and Nurse, 1989; Solomon et al., 1990; 
Krek and Nigg, 1991a) and that mutation of this site to 
nonphosphorylatable residues in fission yeast  results  in pre- 
mature  entry  into mitosis (Gould and Nurse, 1989; Norbury 
et al., 1991; Krek and Nigg, 1991b). As Tyr15 is the only site 
of tyrosine  phosphorylation on cdc2 identified  in this  study 
and  others (Gould and Nurse, 1989; Krek  and Nigg, 1991a; 
Norbury et al., 1991), our results also agree with other evi- 
dence  that  treatment of cdc2 with cdc25 results  in the com- 
plete loss of phosphotyrosine from cdc2 (Kumagai and  Dun- 
B. G. Gabrielli and J. L. Maller,  manuscript  in  preparation. 
phy, 1991; Strausfeld et al., 1991; Lee et al., 1992). 
A  significant difference between cdk2 and cdc2 regulation 
during the embryonic cell cycle is evident in the fact that 
cdk2 activity decreases only 2-3-fold in interphase, whereas 
cdc2 kinase decreases 10-20-fold. It was possible to reduce 
cdk2  activity to below the normal interphase level  by addition 
of DNA/aphidicolin to  extracts,  but even under  those condi- 
tions cdk2 kinase  activity was not completely inhibited. These 
results could be accounted for by at  least three possible 
explanations. The  first is that two pools of cdk2 kinase exist, 
one that is highly regulated, and a second that is less sensitive 
or insensitive to regulation.  A second possible explanation is 
that  the  interphase phosphorylation of cdk2 reduces the  H1 
kinase  activity of the cdk2 complex, but does not completely 
inactivate it, in contrast  to  the case of cdc2 kinase (Parker et 
al., 1992), where the cdc25-sensitive phosphorylation sites  are 
directly  in the  ATP-binding site.  Finally, only cdk2 in  certain 
cellular compartments may be subject to inhibition.  We are 
currently unable to differentiate between these possibilities. 
The regulation of cdk2 raises some interesting questions 
about  the activity of cdc25 during the cell cycle. In  the frog 
embryonic system, the activation of cdk2 and cdc2 kinases 
occurs at a similar stage of the cell cycle although cdk2 is 
consistently  activated slightly before cdc2. Several cdc25 hom- 
ologs have been cloned by ourselves and  others, although any 
differences in their kinetics of activation are  not known at  
present. Recently, it  has been reported that in  somatic cells 
cdk2 is activated in early S-phase (Rosenblatt et al., 1992), 
suggesting the possibility that  at least some isoforms of cdc25 
may be active very early  in the cell cycle. This is unexpected 
from investigations of cyclin B-cdc2 regulation in which 
Tyr"-phosphorylated cyclin B/cdc2 complexes accumulate 
until very near  the G2/M  boundary (Gould and Nurse, 1989; 
Solomon et al., 1990; Meijer et al., 1991). An unknown  event, 
possibly phosphorylation, then activates cdc25 to dephos- 
phorylate and activate cdc2 kinase at  the G2/M boundary. 
Early activation of cdk2 could also reflect the relatively higher 
abundance of the cdk2 kinase complex early  in the cell  cycle 
compared to  the level of cyclin B/cdc2. The timing of cyclin 
B/cdc2 dephosphorylation could also reflect changes in the 
localization of cdc25 or  the movement of cyclin B/cdc2 into 
the nucleus at  the  onset of prophase as reported by Pines  and 
Hunter (1991b) for cultured cells. Clearly more detailed in- 
vestigation of the activity and regulation of various cdc25 
isoforms during the cell cycle and localization of cdk2 is 
necessary to evaluate  temporal differences in  phosphorylation 
and dephosphorylation of cdk2 and cdc2. 
We have shown that  human cdc25 can act on frog cdk2. 
While the  human enzyme modulates frog cdk2 activity  in  a 
manner similar to  that observed in  vivo, we cannot exclude 
the possibility that  human cdc25 loses some essential speci- 
ficity when used across species lines. An example of such a 
loss is the ability of human mitotic cyclins to functionally 
complement loss of budding yeast G1 cyclins, whereas the 
yeast  mitotic cyclin is  unable to do so (Lew et al., 1991). Thus 
it is possible that functional analogs of cdc25 exist  in Xenopus 
eggs which specifically regulate cdk2 activity. A precedent for 
this is the discovery of the weel+ functional homolog, mikl, 
which can rescue a wee- mutant in S. pombe (Lundgren et al., 
1991). Data presented in  that  paper suggested that mikl may 
have a specific role in  regulating the cdc2 prereplicative 
START function thought  to be assumed by cdk2 in higher 
eukaryotes. Direct purification from Xenopus eggs  of the 
phosphatase(s)  that  act on the cdk2 regulatory sites will be 
required to unequivocally establish which enzymes are acting 
in  vivo. 
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